Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haneda

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|June 3, 1999
A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantationM Murata, T Nishida, M Haneda, et al.
Diabetes|May 20, 1999
Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetesS Maeda, M Haneda, H Yasuda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 1, 1984
[Studies on a plastic container for aqueous infusion]M Kikuchi, T Morita, M Haneda, et al.
The Journal of Biological Chemistry|January 5, 1996
Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cellsT Sugimoto, M Haneda, M Togawa, et al.
Diabetologia|November 11, 2011
Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in miceY Takeda, Y Fujita, J Honjo, et al.
Clinical Pharmacology and Therapeutics|May 1, 2009
Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assayY Kurata, M Kato, T Kuzuya, et al.
Diabetologia|April 6, 2012
Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25)H Yokoyama, S Araki, M Haneda, et al.
Diabetes Care|November 28, 2001
Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patientsE Suzuki, A Kashiwagi, Y Nishio, et al.
The American Journal of Physiology|December 22, 1999
Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic ratsA Kashiwagi, K Shinozaki, Y Nishio, et al.
Clinical Nephrology|January 5, 2002
Association of the DD genotype and development of Japanese type 2 diabetic nephropathyT Gohda, Y Makita, T Shike, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|June 3, 1999
A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantationM Murata, T Nishida, M Haneda, et al.
Diabetes|May 20, 1999
Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetesS Maeda, M Haneda, H Yasuda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 1, 1984
[Studies on a plastic container for aqueous infusion]M Kikuchi, T Morita, M Haneda, et al.
The Journal of Biological Chemistry|January 5, 1996
Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cellsT Sugimoto, M Haneda, M Togawa, et al.
Diabetologia|November 11, 2011
Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in miceY Takeda, Y Fujita, J Honjo, et al.
Clinical Pharmacology and Therapeutics|May 1, 2009
Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assayY Kurata, M Kato, T Kuzuya, et al.
Diabetologia|April 6, 2012
Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25)H Yokoyama, S Araki, M Haneda, et al.
Diabetes Care|November 28, 2001
Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patientsE Suzuki, A Kashiwagi, Y Nishio, et al.
The American Journal of Physiology|December 22, 1999
Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic ratsA Kashiwagi, K Shinozaki, Y Nishio, et al.
Clinical Nephrology|January 5, 2002
Association of the DD genotype and development of Japanese type 2 diabetic nephropathyT Gohda, Y Makita, T Shike, et al.
Pageof 15